Kenneth Shinozuka, PhD, is a postdoctoral fellow conducting research on the neuroscience of psychedelics. He is interested in psychedelics as tools for treating a wide range of psychiatric conditions, especially in veterans, and for advancing the study of consciousness. During his postdoc, Kenneth analyzes brain data from veterans who were administered ibogaine, a psychedelic drug, to treat symptoms of traumatic brain injury. Previously, Kenneth received his B.A. in neuroscience from Harvard University and his PhD in psychiatry from the University of Oxford, where he specialized in psychedelic research.

Randi Brown is an Associated Health Fellow in the WOMEN CoE and WRIISC. She completed her degree in clinical psychology at Palo Alto University. Randi’s interests center on examining the efficacy and safety of novel protocols emerging from interventional psychiatry (neuromodulation, psychedelic medicines, etc.) to improve outcomes for people with treatment-resistant depression and PTSD. Additionally, Randi is interested in how these treatments may be modified and optimized to support female Veterans as well as Veterans who have these conditions in the context of traumatic brain injury (TBI) and/or toxic exposures.